Rallis India Q1 PAT climbs 31% to ₹125 cr on broad-based growth
Revenue rose 7% to ₹1,022 crore, led by a 19% jump in domestic B2C. Seeds revenue up 6% on new hybrid launches. But the quarterly release is a routine event with no surprise strategic moves.
— 3 earlier stories on Rallis India Ltd. →What's new
- Revenue up 7% to ₹1,022 cr, PAT up 31% to ₹125 cr.
- Crop care B2C grew 19%; contract manufacturing exports declined.
- Seeds revenue rose 6% to ₹325 cr on nine new hybrid launches.
- Soil & plant health segment expanded 10% aided by new fertilisers.
Why this matters
The 31% PAT growth reflects disciplined pricing and portfolio strength, but this is a routine quarterly earnings release. The market already prices in seasonal variance; no unexpected strategic development here to move the stock materially.
What we're watching
- Sustainability of B2C momentum amid agro-price volatility.
- Outlook for contract manufacturing exports — currently a drag.
- Next catalysts: monsoon progress and new product adoption.
The full read
Rallis India lifted PAT 31% to ₹125 crore in Q1 FY27. Revenue climbed 7% to ₹1,022 crore. The domestic B2C crop care segment jumped 19%, while seeds revenue rose 6% to ₹325 crore on nine new hybrid launches. Solid. The soil and plant health segment added 10%. These results show disciplined pricing and portfolio investments paying off. But this is a routine quarterly release; the market already prices in seasonal variance. There is no unexpected strategic move here. At a P/E of 24.1 and debt-free balance sheet, the valuation reflects steady expectations. The next test is whether B2C momentum can hold if agro-commodity prices soften.
Questions answered
- What drove the 31% PAT growth despite only 7% revenue growth?
- Margin expansion from disciplined pricing and portfolio mix improvements, plus cost optimisation, lifted profit faster than revenue.
- Which segment contributed most to the revenue growth?
- The crop care domestic B2C segment grew 19%, offsetting a decline in contract manufacturing exports.
- How did the seeds business perform?
- Seeds revenue rose 6% to ₹325 crore, helped by the launch of nine new hybrids across cotton, paddy, and millet.
- Is the soil & plant health segment significant?
- It grew 10% supported by biostimulants and new fertilisers, but its absolute contribution is smaller than crop care and seeds.
- Why is this result considered routine?
- The earnings are in line with expectations and lack a strategic surprise (e.g., no major order or M&A), so stock reaction is likely muted.
Rallis India Ltd.
Latest quarter · Mar 2022
Strength & growth
Story so far
All notes on RALLIS →- 20 Jul 2026 · 8:18 PM IST Rallis India Q1 PAT climbs 31% to ₹125 cr on broad-based growth
- today Rallis India pulls back on seed growth, pricing pass-through weakens
- 1d ago Rallis India profit jumps 32% on ₹35 cr one-time boost
- 1d ago Rallis Q1 profit up 32%, but the story is déjà vu